GlassScriptPhysician profile
Hanan Goldberg
NPI 1659917243
$104,983.24
in general payments reported to CMS, 2019-2025
37 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $395 · 2021: $204 · 2022: $2,140 · 2023: $30K · 2024: $31K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Consulting Fee: $28K · Travel and Lodging: $15K · Food and Beverage: $6,973 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,850.00 |
| Consulting Fee | $28,297.39 |
| Travel and Lodging | $15,023.95 |
| Food and Beverage | $6,973.39 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $60,452.72 | 2022-2025 | |
| Pfizer INC. | $18,913.20 | 2022-2025 | |
| Telix Pharmaceuticals | $13,550.73 | 2025 | Illuccix, Gozellix |
| Novartis Pharmaceuticals Corporation | $5,073.99 | 2024-2025 | |
| Teleflex LLC | $2,594.85 | 2021-2024 | |
| Procept Biorobotics Corporation | $690.99 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $447.08 | 2021-2025 | Myrisk, Prolaris |
| Neotract INC. | $376.64 | 2020 | |
| Astellas Pharma US INC | $373.07 | 2023-2025 | Xtandi |
| Myovant Sciences INC. | $282.77 | 2022 | |
| Sun Pharmaceutical Industries INC. | $227.92 | 2025 | |
| Blue Earth Diagnostics | $210.00 | 2024-2025 | Posluma |
| Olympus America INC. | $200.12 | 2023-2025 | Bovie, Olympus, Uropass |
| Dendreon Pharmaceuticals LLC | $166.92 | 2022-2023 | Provenge |
| Boston Scientific Corporation | $149.03 | 2023-2024 | Lithovue, Moses 550 Dfl |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $144.81 | 2021-2025 | Erleada |
| Astellas Pharma INC | $140.88 | 2024 | Xtandi |
| Sumitomo Pharma America, INC. | $127.70 | 2023-2025 | Orgovyx |
| Urogen Pharma, INC. | $109.22 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $89.13 | 2023-2025 | Lynparza, Keytruda |
| Ferring Pharmaceuticals INC. | $87.14 | 2025 | Adstiladrin |
| Intuitive Surgical, INC. | $65.67 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $63.76 | 2023-2024 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Edap Technomed INC | $58.13 | 2023 | |
| Ambu INC. | $56.37 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $47.69 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Shionogi INC | $42.62 | 2024-2025 | Fetroja |
| Immunitybio, INC. | $41.21 | 2024-2025 | |
| Coloplast Corp | $32.26 | 2023-2024 | Speedicath |
| Dentsply Ih INC. | $27.07 | 2024 | Lofric |
| 180 Medical, INC. | $25.88 | 2024 | |
| Progenics Pharmaceuticals, INC. | $25.22 | 2025 | |
| Endo Pharmaceuticals INC. | $22.36 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.39 | 2025 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $18.56 | 2020 | |
| Axonics, INC. | $13.75 | 2024 | Axonics, Bulkamid |
| Allergan, INC. | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanan Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.